DDX41 and Parkinson disease: The level of Abs against other immunogenic peptides (LtxA1429–445, LtxA264–80, EBNA1400–413, BOLF1305–320, MAP402718–32, MAP1,4-α-gbp157–173, MAP3865c125–133 peptides) did not statistically differ between PD patients and HCs (p > 0.05).